XML 305 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Segment Results) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Sales $ 29,453 $ 22,284 $ 17,911
Operating profit 7,465 4,231 3,269
Depreciation and amortization of intangible assets 2,168 1,775 1,189
Identifiable assets 83,184 76,161 62,082
Capital expenditures, gross 1,294 791 636
Operating segments | Life Sciences      
Segment Reporting Information [Line Items]      
Sales 14,958 10,576 6,951
Operating profit 4,367 2,054 1,401
Depreciation and amortization of intangible assets 1,441 1,053 487
Capital expenditures, gross 595 306 143
Operating segments | Life Sciences | Continuing operations      
Segment Reporting Information [Line Items]      
Identifiable assets 57,886 48,919 22,381
Operating segments | Diagnostics      
Segment Reporting Information [Line Items]      
Sales 9,844 7,403 6,561
Operating profit 2,313 1,538 1,134
Depreciation and amortization of intangible assets 614 602 582
Capital expenditures, gross 644 447 435
Operating segments | Diagnostics | Continuing operations      
Segment Reporting Information [Line Items]      
Identifiable assets 15,054 15,042 14,442
Operating segments | Environmental & Applied Solutions      
Segment Reporting Information [Line Items]      
Sales 4,651 4,305 4,399
Operating profit 1,054 979 1,052
Depreciation and amortization of intangible assets 106 110 111
Capital expenditures, gross 54 36 54
Operating segments | Environmental & Applied Solutions | Continuing operations      
Segment Reporting Information [Line Items]      
Identifiable assets 4,882 5,083 4,882
Other      
Segment Reporting Information [Line Items]      
Operating profit (269) (340) (318)
Depreciation and amortization of intangible assets 7 10 9
Capital expenditures, gross 1 2 4
Other | Continuing operations      
Segment Reporting Information [Line Items]      
Identifiable assets $ 5,362 $ 7,117 $ 20,377